NCT03885635

Brief Summary

HEADSTART is a prospective, open-label, non-blinded, multicenter, randomized controlled trial that compares a composite of mortality and re-intervention in patients undergoing hemiarch and extended arch repair for acute DeBakey type 1 aortic dissection. Eligible patients will be randomized to one or the other surgical strategy and clinical and imaging outcome data will be collected over a 3 year follow up period.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
9mo left

Started Jul 2024

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Jul 2024Mar 2027

First Submitted

Initial submission to the registry

March 16, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 21, 2019

Completed
5.4 years until next milestone

Study Start

First participant enrolled

July 30, 2024

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2027

Last Updated

September 22, 2025

Status Verified

August 1, 2025

Enrollment Period

2.7 years

First QC Date

March 16, 2019

Last Update Submit

September 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of patients experiencing a composite end-point of mortality or re-intervention

    Compare the proportion of patients between the two groups who over a 3 year follow up period attain a composite clinical end-point of 1) mortality, 2) late aortic re-intervention, either surgical or endovascular (\> 30 days from index procedure) or 3) early (\< 30 days from index procedure) re-intervention for branch malperfusion

    3 years

Secondary Outcomes (6)

  • Number of patients achieving complete false lumen thrombosis on CT imaging

    3 years

  • Delta change in the ratio of true lumen to total aortic area (TL: Ao)

    1 month

  • Delta change in maximum cross-sectional descending thoracic aortic dimension

    3 years

  • Number of patients experiencing the listed peri-operative complications

    1 month

  • Number of patients requiring open surgical or endovascular re-intervention

    3 years

  • +1 more secondary outcomes

Study Arms (2)

Hemiarch repair

ACTIVE COMPARATOR

Standard hemiarch repair with open distal anastomosis in the proximal arch without replacement of the head vessels.

Procedure: Hemiarch repair

Extended arch repair

ACTIVE COMPARATOR

Ascending aortic and arch replacement with or without head vessel re-implantation and single TEVAR device placement within 1 week.

Procedure: Extended arch repair

Interventions

Current standard of surgical repair consisting of ascending aortic replacement with open distal anastomosis at level of proximal arch under a period of hypothermic circulatory arrest . No surgical or endovascular intervention is carried out in the mid arch or descending aorta. Intra-operative management, including cannulation, cardioplegia, cerebral perfusion technique, and neurologic monitoring will be done according to each institution's current standard of practice.

Hemiarch repair

Surgical replacement of the ascending aorta along with intervention on the arch and descending aorta. Techniques for distal aspect of extended arch technique include but are not limited to total arch replacement along with TEVAR, Frozen Elephant Trunk procedure or surgical proximal arch replacement with bare metal stents in arch and descending aorta. Intra-operative management, including cannulation, cardioplegia, cerebral perfusion technique, and neurologic monitoring will be done according to each institution's current standard of practice.

Extended arch repair

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Emergent surgical repair of Acute DeBakey Type 1 aortic dissection
  • Age \>18 years and \<70 years
  • Operating surgeon believes that both surgeries could be safe and effective

You may not qualify if:

  • Hemodynamic instability/shock defined as systolic BP \< 90 mm Hg
  • Previous cardiac surgery with sternotomy or thoracic endograft placement
  • Aortic arch diameter \> 6cm in which a concomitant arch replacement is judged necessary
  • Procedures deemed to be "salvage operations" where the patient is unlikely to survive hospital discharge.
  • GCS \< 8 for more than 6 hours
  • History of cirrhosis.
  • History of chronic renal failure (baseline eGFR \< 50)
  • Metastatic malignancy
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

London Health Sciences Centre

London, Ontario, N6A5A5, Canada

RECRUITING

University Health Network

Toronto, Ontario, M5G 2C4, Canada

RECRUITING

Montreal Heart Institute

Montreal, Quebec, H1T 1C8, Canada

RECRUITING

Institut Universitaire De Cardiologie Et De Pneumologie de Québec

Québec, Quebec, G1V 4G5, Canada

RECRUITING

Related Publications (1)

  • Elbatarny M, Stevens LM, Dagenais F, Peterson MD, Vervoort D, El-Hamamsy I, Moon M, Al-Atassi T, Chung J, Boodhwani M, Chu MWA, Ouzounian M; Canadian Thoracic Aortic Collaborative Investigators. Hemiarch versus extended arch repair for acute type A dissection: Results from a multicenter national registry. J Thorac Cardiovasc Surg. 2024 Mar;167(3):935-943.e5. doi: 10.1016/j.jtcvs.2023.04.012. Epub 2023 Apr 20.

MeSH Terms

Conditions

Aortic Dissection

Condition Hierarchy (Ancestors)

Dissection, Blood VesselAneurysmVascular DiseasesCardiovascular DiseasesAcute Aortic SyndromeAortic Diseases

Study Officials

  • Munir Boodhwani, MD

    Ottawa Heart Institute Research Corporation

    PRINCIPAL INVESTIGATOR
  • Jehangir Appoo, MD

    University of Calgary

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Hemiarch vs. extended arch repair in the setting of acute DeBakey type 1 aortic dissections
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 16, 2019

First Posted

March 21, 2019

Study Start

July 30, 2024

Primary Completion (Estimated)

March 31, 2027

Study Completion (Estimated)

March 31, 2027

Last Updated

September 22, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations